BPH Energy Ltd
ASX:BPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BPH Energy Ltd
Accumulated Depreciation
BPH Energy Ltd
Accumulated Depreciation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BPH Energy Ltd
ASX:BPH
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Accumulated Depreciation
-AU$3.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Accumulated Depreciation
-AU$30.8m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Accumulated Depreciation
-AU$4.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Accumulated Depreciation
-AU$392.9k
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
BPH Energy Ltd
Glance View
BPH Energy Ltd. engages in the development of biomedical research and technologies within universities and hospital institutes. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-08-06. The Company’s principal activities include Cortical Dynamics, Advent Energy Limited, Molecular Discovery Systems (MD Systems) and the HLS5 Project. Cortical Dynamics is working with BPH Energy and Swinburne University of Technology to develop and commercialize anaesthesia monitoring systems for use during surgery. Advent Energy Limited holds a portfolio of exploration assets throughout Australia and has its project in petroleum exploration permit 11. MD Systems is a class of anti-mitotic drugs, which has undergone preclinical testing of anti-cancer activity. MD Systems is working with the Western Australian Institute for Medical Research to develop and validate HLS5 as a tumor suppressor gene.
